Replies to post #126248 on Biotech Values

[DewDiligence]

Re: Epogen FoB from PFE/(HSP)

PFE disclosed on today’s 3Q15 CC that the FDA issued a CRL for the 351(k) application submitted by HSP (prior to PFE’s buyout). PFE said it would resubmit the aBLA with additional data.